Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Nanoscale Adv ; 4(20): 4418-4433, 2022 Oct 11.
Article in English | MEDLINE | ID: mdl-36321152

ABSTRACT

Herein, a novel designed antimicrobial therapeutic drug delivery system is presented, in which halloysite nanotubes (HNTs) encapsulate a determined dosage of levofloxacin (lvx). Moreover, gold nanoparticles (AuNPs) have been embedded into the structure for plasmonic heating under irradiation of the green LED light (7 W, 526 nm). It was revealed that the plasmonic heating of the AuNPs leads to a controlled trend in the lvx release process. Also, a synergistic effect on the antimicrobial activity of the prepared therapeutic system has been observed through photothermal heating of the structure. To enhance the cell adhesion, a cell-penetrating peptide sequence (CPP) is conjugated to the surfaces. This CPP has led to quick co-localization of the prepared nano-cargo (denoted as lvx@HNT/Au-CPP) with the bacterial living cells and further attachment (confirmed by confocal microscopy). Concisely, the structure of the designed nano-cargo has been investigated by various methods, and the in vitro cellular experiments (zone of inhibition and colony-counting) have disclosed that the antimicrobial activity of the lvx is significantly enhanced through incorporation into the HNT/Au-CPP delivery system (drug content: 16 wt%), in comparison with the individual lvx with the same dosage. Hence, it can be stated that the bacterial resistance against antibiotics and the toxic effects of the chemical medications are reduced through the application of the presented strategy.

2.
RSC Adv ; 13(1): 80-114, 2022 Dec 19.
Article in English | MEDLINE | ID: mdl-36605676

ABSTRACT

In the field of targeted drug delivery, the effects of size and morphology of drug nanocarriers are of great importance and need to be discussed in depth. To be concise, among all the various shapes of nanocarriers, rods and tubes with a narrow cross-section are the most preferred shapes for the penetration of a cell membrane. In this regard, several studies have focused on methods to produce nanorods and nanotubes with controlled optimized size and aspect ratio (AR). Additionally, a non-spherical orientation could affect the cellular uptake process while a tangent angle of less than 45° is better at penetrating the membrane, and Ω = 90° is beneficial. Moreover, these nanocarriers show different behaviors when confronting diverse cells whose fields should be investigated in future studies. In this survey, a comprehensive classification based on carrier shape is first submitted. Then, the most commonly used methods for control over the size and shape of the carriers are reviewed. Finally, influential factors on the cellular uptake and internalization processes and related analytical methods for evaluating this process are discussed.

3.
Small ; 16(41): e2002733, 2020 10.
Article in English | MEDLINE | ID: mdl-32945130

ABSTRACT

A versatile breast cancer-targeting nanocomposite therapeutic combining docetaxel (DXL), polyvinyl alcohol (PVA) network for controlled release, and silica-protected magnetic iron oxide nanoparticles (Fe3 O4 NPs) for targeted delivery and gold nanoparticles (AuNPs) for plasmonic photothermal therapy (PPTT) is presented in this work. First, the designed nanocomposite is magnetically directed for cancer-targeted therapy confirmed by computerized tomography (CT) scans. Second, 10% DXL by mass is loaded into PVA, a pH and temperature responsive gel, for controlled release. Third, PPTT is confirmed with Au/Fe3 O4 /PVA-10%DXL using a prototype circulation system and then for tumor treatment in vivo; Au/Fe3 O4 /PVA-10%DXL is conveniently directed and the entrapped DXL is selectively released (≈96%) via the interaction of green and near-infrared (NIR) light with the localized surface plasmon resonance of AuNPs. A 75% cell death is reported from in vitro studies with DXL doses as low as 20 µg mL-1 of Au/Fe3 O4 /PVA-10%DXL, and a 70% tumor growth inhibition is demonstrated by in vivo experiments with the biosafety studies confirming minimal side effects to other organs. Overall, the developed Au/Fe3 O4 /PVA-10%DXL has a strong potential to simultaneously enhance CT imaging contrast together with the targeted delivery of DXL.


Subject(s)
Breast Neoplasms , Metal Nanoparticles , Nanocomposites , Breast Neoplasms/drug therapy , Docetaxel , Female , Gold , Humans
4.
RSC Adv ; 10(71): 43670-43681, 2020 Nov 27.
Article in English | MEDLINE | ID: mdl-35519713

ABSTRACT

Herein, silver nanoparticles (Ag NPs), as an effective catalyst for the reduction process of nitrobenzene derivatives to non-hazardous and useful aniline derivatives, are conveniently synthesized on an inherently magnetic substrate. For this purpose, an efficient combination of volcanic pumice (VP), which is an extremely porous igneous rock, and a chitosan (CTS) polymeric network is prepared and suitably used for the stabilization of the Ag NPs. High magnetic properties of the fabricated Ag@VP/CTS composite, which have been confirmed via vibrating-sample magnetometer (VSM) analysis, are the first and foremost advantage of the introduced catalytic system since it gives us the opportunity to easily separate the particles and perform purification processes. Briefly, higher yields were obtained in the reduction reactions of nitrobenzenes (NBs) under very mild conditions in a short reaction time. Also, along with the natural biocompatible ingredients (VP and CTS) in the structure, excellent recyclability has been observed for the fabricated Ag@VP/CTS catalytic system, which convinces us to do scaling-up and suggests the presented system can be used for industrial applications.

SELECTION OF CITATIONS
SEARCH DETAIL
...